Physician profile
Andrew Mueller
NPI 1053773580
$3,621.91
in general payments reported to CMS, 2019-2025
18 companies · $927 in 2025
The $927 reported for 2025 was more than what 75% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $30.66 · 2021: $195 · 2022: $538 · 2023: $568 · 2024: $1,364 · 2025: $927.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,859.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,858.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $604.52 | 2024-2025 | Tepezza, Uplizna |
| Alcon Vision LLC | $587.90 | 2021-2025 | Constellation, Clareon, Hydrus Microstent |
| Apellis Pharmaceuticals, INC. | $368.64 | 2022-2025 | Syfovre |
| Horizon Therapeutics Plc | $349.95 | 2021-2023 | Tepezza |
| Abbvie INC. | $286.62 | 2022-2025 | |
| Tarsus Pharmaceuticals, INC. | $276.91 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $270.08 | 2024-2025 | Oxervate |
| Harrow Eye, LLC | $196.43 | 2024 | Iheezo |
| Galderma Laboratories, L.P. | $146.55 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $110.25 | 2024 | Eylea Hd |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $108.67 | 2020-2021 | |
| Lkc Technologies, INC. | $80.00 | 2024 | |
| Aerie Pharmaceuticals, INC. | $58.98 | 2020-2021 | |
| Bausch & Lomb Americas INC. | $51.86 | 2022-2023 | Vyzulta |
| Kala Pharmaceuticals, INC. | $44.89 | 2021-2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $38.60 | 2022 | |
| Mallinckrodt Hospital Products INC. | $20.68 | 2022 | |
| Rayner Intraocular Lenses Limited | $20.38 | 2024 | Omidria |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Mueller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.